Tvardi Therapeutics, Inc. (“Tvardi”) a privately held, clinical-stage biopharmaceutical company focused on the development of…
On Childhood Cancer Day, SHEPHERD Therapeutics is joining forces with Oncoheroes Biosciences to bring new treatment options to children and adolescents with cancer. SHEPHERD is a Boston-based biotech company on a mission to change the way rare cancer is treated, including childhood cancers.
“SHEPHERD and Oncoheroes are coming together in hope and in action, leveraging the full extent of our combined technology, experience, and expertise to help save lives,” said David Hysong, CEO of SHEPHERD.
Read more: https://oncoheroes.com/press-releases-content/2021/2/12/shepherd-therapeutics-and-oncoheroes-biosciences-to-partner-for-the-discovery-development-and-commercialization-of-oncology-therapeutics-for-rare-cancers?ss_source=sscampaigns&ss_campaign_id=60269df0bb649d04e8937b30&ss_email_id=602aa8cd0c09d041379337d6&ss_campaign_name=NEWS%21+Oncoheroes+%26+SHEPHERD+Therapeutics+United+Against+Rare+Cancers&ss_campaign_sent_date=2021-02-15T17%3A01%3A48Z